Skip to main content
. 2017 Feb 23;6(1):16. doi: 10.3390/antiox6010016

Table 1.

Participant characteristics.

Parameter Men (n = 6) Women (n = 15) EF (n = 5) LF (n = 5) ML (n = 5)
Age (years) 21.8 ± 0.9 21.7 ± 2.4 20.7 ± 0.5 23.3 ± 2.4 21.2 ± 4.4
Body mass (kg) 71.4 ± 10.5 58.0 ± 10.2 a 55.6 ± 7.8 57.6 ± 4.9 60.8 ± 16.2
Height (cm) 179.2 ± 8.5 160.6 ± 5.5 a 158.1 ± 5.6 a 161.6 ± 3.1 a 162.1 ± 7.2 a
BMI (kg/m2) 22.1 ± 1.8 22.4 ± 3.4 22.5 ± 4.7 22.0 ± 1.2 22.8 ± 4.0
17β-Oestradiol (pmol/L) 156.7 ± 51.6 552.3 ± 435.7 a 166.0 ±88.8 990.8 ± 406.6 a,b,c 500.0 ± 246.6 a,b
Progesterone (nmol/L) 2.7 ± 0.5 10.8 ± 12.0 2.3 ± 0.9 4.1 ± 1.5 25.9 ± 8.2 a,b,d
Length of MC (days) 29.4 ± 4.5 29.2 ± 5.3 29.2 ± 5.8 29.8 ± 2.5
MC day of running 3.6 ± 1.1 14.4 ± 2.7 20.4 ± 2.2

EF, early follicular; LF, late follicular; ML, mid-luteal; BMI, body mass index; MC, menstrual cycle. a denotes a significant difference to Men, p < 0.01; b denotes a difference to EF, p < 0.01; c denotes a trend for difference to ML, p = 0.09; d denotes a difference to LF, p < 0.0001.